Federal officials granted the American company Bioquark, the permission to continue with its groundbreaking medical research that would give answers to the question whether the brains of dead people could be restored to its normal state. It was the review board of the National Institutes of Health in both the United States and India that gave the go signal for the start of the project that aims to reverse death.
Bioquark said that death may be not reversible but they have the time has come to 'push the envelope' and confirm if that is really how it is. The project, which has been has been dubbed as the "Lazarus trial," is now underway and it was all thanks to the regulatory boards that approved the first stage of testings, Daily Mail UK reported.
With the go signal, Bioquark is now looking for 20 patients who can participate in the program. The subjects must be clinically dead already and only breathing through life support. The scientists will use their brains to see if portions of their central nervous system could be regenerated to give the person a chance to come back to life.
It was revealed that the doctors will apply various therapy methods for the test like administering the brain with stem cells and mix of peptides as well as using lasers and nerve simulation procedures which have been known to help patients to come out of coma.
In a press release, Bioquark Inc. CEO Ira S. Pastor said, "We are very excited about the approval of our protocol. With the convergence of the disciplines of regenerative biology, cognitive neuroscience, and clinical resuscitation, we are poised to delve into an area of scientific understanding previously inaccessible with existing technologies."
The tests on patients will be carried out at Anupam Hospital in Rudrapur, Uttarakhand India. Pastor stated that they are hoping to see results in the first two to three months from the start of the testings, but the trial is set to run for about a year.
Lastly, Bioquark reiterated that even if their research will not be successful in its aim to bring the dead back to life, it is hoping that the research project will still be useful in other areas and paved the way for the development of treatments for age-related neurological diseases.
US biotech company Bioquark got approval to move forward with its research that aims to reverse brain death in patients on life support, see the report below: